Aldehyde Fuchsin

FDA classification

FDA Class 1 ·Aldehyde Fuchsin

Calprotectin, Fecal

FDA classification

FDA Class 2 ·Calprotectin, Fecal

Porter Silber Hydrazone, 17-Hydroxycorticosteroids

FDA classification

FDA Class 1 ·Porter Silber Hydrazone, 17-Hydroxycorticosteroids

Ceruloplasmin, Antigen, Antiserum, Control

FDA classification

FDA Class 2 ·Ceruloplasmin, Antigen, Antiserum, Control

Bracket, Plastic, Orthodontic, Reprocessed

FDA classification

FDA Class 2 ·Bracket, Plastic, Orthodontic, Reprocessed

Research Laser

FDA classification

FDA Not Classified ·Research Laser

Antigen, Id, Candida Albicans

FDA classification

FDA Class 2 ·Antigen, Id, Candida Albicans

Rf Identification

FDA classification

FDA Not Classified ·Rf Identification

Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer

FDA classification

FDA Class 3 ·Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer

Liver Iron Concentration Imaging Companion Diagnostic For Deferasirox

FDA classification

FDA Class 2 ·Liver Iron Concentration Imaging Companion Diagnostic For Deferasirox

Candida Spp., Direct Antigen, Id

FDA classification

FDA Class 2 ·Candida Spp., Direct Antigen, Id

Reprocessed Bronchoscope

FDA classification

FDA Class 2 ·Reprocessed Bronchoscope

Thermocycler, Generic

FDA classification

FDA Class 1 ·Thermocycler, Generic

Implantable Radio Frequency Transponder System

FDA classification

FDA Class 2 ·Implantable Radio Frequency Transponder System

Antigen, Cf And / Or Id, Coccidioides Immitis

FDA classification

FDA Class 2 ·Antigen, Cf And / Or Id, Coccidioides Immitis

Antigen, Id, Ha, Cep, Entamoeba Histolytica & Rel. Spp.

FDA classification

FDA Class 2 ·Antigen, Id, Ha, Cep, Entamoeba Histolytica & Rel. Spp.

Non-Implanted Nerve Stimulator For Pain Associated With Irritable Bowel Syndrome (Ibs)

FDA classification

FDA Class 2 ·Non-Implanted Nerve Stimulator For Pain Associated With Irritable Bowel Syndrome (Ibs)

System, Microarray-Based, Genome-Wide, Postnatal Chromosomal Abnormality Detection

FDA classification

FDA Class 2 ·System, Microarray-Based, Genome-Wide, Postnatal Chromosomal Abnormality Detection